» Articles » PMID: 30787272

Succinylation-dependent Mitochondrial Translocation of PKM2 Promotes Cell Survival in Response to Nutritional Stress

Overview
Journal Cell Death Dis
Date 2019 Feb 22
PMID 30787272
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor growth and progression is characteristically associated with the synergistic effects of uncontrolled cellular proliferation and cell survival under stress. Pyruvate kinase M2 (PKM2) contributes to both of these effects. However, the specific mechanism by which PKM2 promotes uncontrolled proliferation or cell survival under stress in different nutritional environments is unclear. We show that succinylation mediated mitochondrial translocation of PKM2 under glucose starvation plays a role in switching the cellular machinery from proliferation to cell survival mode and vice versa. Mitochondrial PKM2 inhibits ubiquitination-mediated degradation of voltage-dependent anion channel 3 (VDAC3) and increases mitochondrial permeability to generate more ATP for cell survival under nutritional depletion. We found there is a positive correlation of upregulation of mitochondrial PKM2 and upregulation of VDAC3 in human colon cancer. This shows the mechanisms identified in this study in fact play a role in neoplastic biology. We therefore developed a small molecule designated compound 8 that blocks mitochondrial translocation of PKM2 and inhibits tumor development. Our data suggest that blocking PKM2 mitochondrial function with a small molecule inhibitor has potential for cancer treatment.

Citing Articles

Succinylation enables IDE to act as a hub of larval tissue destruction and adult tissue reconstruction during insect metamorphosis.

Li Y, Shao B, Hou M, Dong D Sci Adv. 2025; 11(6):eads0643.

PMID: 39908369 PMC: 11797550. DOI: 10.1126/sciadv.ads0643.


Unlocking the Hidden Potential of Cancer Therapy Targeting Lysine Succinylation.

Zheng Z, Xiao P, Kuang J, Wang Z, Wang X, Huang D J Cancer. 2025; 16(3):821-834.

PMID: 39781339 PMC: 11705062. DOI: 10.7150/jca.105849.


Mechanisms of drug resistance in nutrient-depleted colorectal cancer cells: insights into lysosomal and mitochondrial drug sequestration.

Kose S, Gulec Taskiran A Biol Open. 2024; 13(10).

PMID: 39445740 PMC: 11554266. DOI: 10.1242/bio.060448.


Expression and prognostic impact of in colorectal adenocarcinoma.

Yang K, Zhu T, Sheng C, Zhu J, Xu J, Fu G Transl Cancer Res. 2024; 13(9):4736-4751.

PMID: 39430839 PMC: 11483328. DOI: 10.21037/tcr-24-402.


Activation and inhibition of sirtuins: From bench to bedside.

Fiorentino F, Fabbrizi E, Mai A, Rotili D Med Res Rev. 2024; 45(2):484-560.

PMID: 39215785 PMC: 11796339. DOI: 10.1002/med.22076.


References
1.
Vander Heiden M, Christofk H, Schuman E, Subtelny A, Sharfi H, Harlow E . Identification of small molecule inhibitors of pyruvate kinase M2. Biochem Pharmacol. 2009; 79(8):1118-24. PMC: 2823991. DOI: 10.1016/j.bcp.2009.12.003. View

2.
Morgan H, OReilly F, Wear M, ONeill J, Fothergill-Gilmore L, Hupp T . M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation. Proc Natl Acad Sci U S A. 2013; 110(15):5881-6. PMC: 3625322. DOI: 10.1073/pnas.1217157110. View

3.
Keller K, Doctor Z, Dwyer Z, Lee Y . SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells. Mol Cell. 2014; 53(5):700-9. PMC: 4000728. DOI: 10.1016/j.molcel.2014.02.015. View

4.
Yang W, Xia Y, Hawke D, Li X, Liang J, Xing D . PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell. 2012; 150(4):685-96. PMC: 3431020. DOI: 10.1016/j.cell.2012.07.018. View

5.
Wang F, Wang K, Xu W, Zhao S, Ye D, Wang Y . SIRT5 Desuccinylates and Activates Pyruvate Kinase M2 to Block Macrophage IL-1β Production and to Prevent DSS-Induced Colitis in Mice. Cell Rep. 2017; 19(11):2331-2344. DOI: 10.1016/j.celrep.2017.05.065. View